Bulletin
Investor Alert

Nektar Therapeutics

NAS: NKTR

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Nektar Therapeutics

After Hours

NKTR
/zigman2/quotes/206715615/composite

$

0.64

Change

+0.01 +1.87%

Volume

Volume 5,406

May 26, 2023, 7:13 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206715615/composite

Previous close

$ 0.64

$ 0.63

Change

-0.0065 -1.02%

Day low

Day high

$0.62

$0.65

Open
Open: 0.64

52 week low

52 week high

$0.60

$5.18

Open

Market cap

$119.63M

Average volume

5.47M

P/E ratio

N/A

Rev. per Employee

$411,236

EPS

-2.21

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nktr

MarketWatch News on NKTR

  3. 20 Stocks for the Next Bull Market

    3:44 p.m. March 27, 2023

    - Barron's Online

  7. Nektar Therapeutics downgraded to underweight from neutral at J.P. Morgan

    7:21 a.m. Aug. 8, 2022

    - Tomi Kilgore

  8. Nektar Therapeutics Will Cut 70% of Its Staff After Trial Failure

    9:19 a.m. April 26, 2022

    - Barron's Online

  9. Nektar to reduce workforce by 70%

    8:53 a.m. April 26, 2022

    - Jaimy Lee

  12. Nektar Therapeutics Stock Tanks Nearly 40%

    9:48 a.m. April 18, 2022

    - Barron's Online

  13. Nektar Therapeutics stock price target cut to $6 from $8 at Mizuho

    6:34 a.m. April 18, 2022

    - Tomi Kilgore

  14. 10 Beaten-Down Stocks Where Short Sellers Are Now Retreating

    8:07 a.m. April 13, 2022

    - Barron's Online

  16. Nektar Therapeutics downgraded to neutral from buy at Mizuho

    7:49 a.m. March 15, 2022

    - Tomi Kilgore

  17. Nektar Therapeutics stock price target cut to $8 from $35 at Mizuho

    7:50 a.m. March 15, 2022

    - Tomi Kilgore

  18. Nektar Shares Halve on Cancer Trial Failure

    6:14 p.m. March 14, 2022

    - Barron's Online

  20. Nektar Therapeutics upgraded to outperform from perform at Raymond James

    8:24 a.m. March 9, 2022

    - Tomi Kilgore

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/nktr

Other News on NKTR

  1. 10-Q: NEKTAR THERAPEUTICS

    6:03 a.m. May 10, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. 10-K: NEKTAR THERAPEUTICS

    6:12 p.m. Feb. 28, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  3. This Insider Just Sold Shares of Nektar Therapeutics

    1:30 p.m. Feb. 18, 2023

    - GuruFocus.com

  6. Nektar's (NKTR) Q3 Earnings and Revenues Beat Estimates

    1:35 p.m. Nov. 4, 2022

    - Zacks.com

  7. Nektar Therapeutics (NKTR) Q3 2022 Earnings Call Transcript

    11:15 p.m. Nov. 3, 2022

    - Seeking Alpha

  13. Nektar's (NKTR) Q2 Earnings and Revenues Miss Estimates

    12:11 p.m. Aug. 5, 2022

    - Zacks.com

  14. 10-Q: NEKTAR THERAPEUTICS

    6:14 a.m. Aug. 5, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  17. CEO Stock Sales Raise Questions About Insider Trading

    7:18 a.m. June 30, 2022

    - The Wall Street Journal Interactive Edition

/news/pressrelease/company/us/nktr

Press Releases on NKTR

  1. Nektar Therapeutics Reports First Quarter 2023 Financial Results

    4:15 p.m. May 9, 2023

    - PR Newswire - PRF

  17. Nektar Therapeutics Reports Third Quarter 2022 Financial Results

    4:15 p.m. Nov. 3, 2022

    - PR Newswire - PRF

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.